Square Pharmaceuticals PLC. (DSE:SQURPHARMA)

DSE:SQURPHARMA Ratios and Metrics

Market cap in millions BDT. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 26, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	181,634	185,180	186,953	185,977	192,094	191,030
Market Cap Growth	-5.79%	-0.95%	0.52%	-3.18%	0.56%	31.17%
Enterprise Value	112,167	126,115	130,781	132,967	141,464	147,209
Last Close Price	204.90	197.14	189.15	178.84	176.04	170.40
PE Ratio	7.58	7.73	8.93	9.80	10.58	11.98
Forward PE	-	7.25	8.30	9.10	9.93	10.40
PS Ratio	2.27	2.43	2.67	3.06	3.34	3.77
PB Ratio	1.22	1.32	1.49	1.61	1.83	2.10
P/TBV Ratio	1.22	1.32	1.49	1.61	1.83	2.10
P/FCF Ratio	12.48	16.65	13.03	32.71	28.71	26.61
P/OCF Ratio	8.84	10.70	10.09	21.76	14.92	17.40
PEG Ratio	-	0.68	0.68	0.70	0.66	0.69
EV/Sales Ratio	1.47	1.65	1.87	2.19	2.46	2.90
EV/EBITDA Ratio	4.53	5.84	6.45	7.00	7.57	8.58
EV/EBIT Ratio	4.97	6.50	7.28	7.97	8.39	9.64
EV/FCF Ratio	7.71	11.34	9.12	23.39	21.14	20.51
Debt / Equity Ratio	0.01	0.01	0.01	0.02	0.02	0.00
Debt / EBITDA Ratio	0.03	0.04	0.07	0.10	0.10	0.01
Debt / FCF Ratio	0.05	0.07	0.10	0.35	0.29	0.01
Asset Turnover	0.54	0.55	0.55	0.52	0.56	0.57
Inventory Turnover	3.05	3.15	3.03	3.18	3.72	3.94
Quick Ratio	9.01	10.22	10.70	13.29	14.30	14.56
Current Ratio	11.20	12.80	13.48	16.67	17.03	17.33
Return on Equity (ROE)	17.98%	18.03%	17.36%	17.22%	18.52%	18.96%
Return on Assets (ROA)	8.70%	8.67%	8.83%	8.93%	10.17%	10.77%
Return on Capital (ROIC)	9.15%	9.04%	9.19%	9.30%	10.64%	11.34%
Return on Capital Employed (ROCE)	13.80%	13.80%	14.10%	14.20%	15.60%	16.50%
Earnings Yield	13.92%	12.94%	11.19%	10.21%	9.45%	8.35%
FCF Yield	8.01%	6.01%	7.67%	3.06%	3.48%	3.76%
Dividend Yield	5.86%	6.09%	5.82%	5.87%	5.68%	3.52%
Payout Ratio	38.41%	40.51%	44.32%	46.38%	29.20%	24.60%
Buyback Yield / Dilution	0.01%	-	-	-	-	-
Total Shareholder Return	5.87%	6.09%	5.82%	5.87%	5.68%	3.52%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.